Skip to main content

Table 4 Levels and reducing percentage of LDL-C and duration in each group in Western and Asian (Mean ± SD)

From: The difference between Asian and Western in the effect of LDL-C lowering therapy on coronary atherosclerotic plaque: a meta-analysis report

Group N Mean LDL-C at baseline (mg) Mean LDL-C at follow up (mg) Mean reducing percentage Actual range of reducing percentage Duration (month)
Western ≤70 mg 905 123.2 ± 6.9 61.9 ± 0.9 49.4 ± 3.5 37 ~ 53 23.1 ± 4.3
>70 ≤ 100 HPmg 812 131.3 ± 15.2 73.6 ± 4.8 43.2 ± 2.2 41.5 ~ 46.7 21.7 ± 3.1
>70 ≤ 100 MPmg 1548 91.3 ± 6.9 82.4 ± 8.2 9.0 ± 4.5 3.6 ~ 14.9 19.8 ± 2.7
>70 ≤ 100 LPmg 1061 88.5 ± 5.5 91.5 ± 5.4 −4.7 ± 2.5 −1.7 ~ −8.5 19.9 ± 4.5
>100 mg 464 123.4 ± 28.9 106.3 ± 4.4 8.7 ± 17.5 −10.9 ~ 25.0 18.0 ± 0.0
>50% 349 130.4 ± 0.0 60.8 ± 0.0 53.4 ± 0.0 53.4 ~ 53.4 24.0 ± 0.0
>40 ≤ 50% 1332 126.9 ± 13.1 69.3 ± 6.5 45.0 ± 2.8 41.5 ~ 47.8 22.6 ± 2.7
>30 ≤ 40% 36 100.2 ± 30.2 63.1 ± 17.4 37.0 37 ~ 37 2.0 ± 0.0
>0 ≤ 30% 1797 99.4 ± 21.4 86.2 ± 12.2 11.2 ± 6.9 3.6 ~ 25.0 19.5 ± 2.6
<0% 1276 89.1 ± 5.3 93.2 ± 6.2 −5.6 ± 3.1 −1.7 ~ −10.9 19.6 ± 4.2
Asian ≤70 mg 345 111.5 ± 4.3 57.0 ± 5.0 47.2 ± 1.7 44 ~ 49 6.9 ± 2.1
>70 ≤ 100 HPmg 540 134.2 ± 7.8 84.0 ± 5.0 36.1 ± 1.8 32.3 ~ 39.0 11.0 ± 2.2
>100 mg 235 128.6 ± 10.5 117.2 ± 11.9 7.3 ± 10.7 0 ~ 32 7.8 ± 2.8
>40 ≤ 50% 345 111.5 ± 4.3 57.0 ± 5.0 47.2 ± 1.7 44 ~ 49 6.9 ± 2.1
>30 ≤ 40% 558 134.7 ± 8.1 84.6 ± 5.8 36.0 ± 1.9 32 ~ 39 10.9 ± 2.4
>0 ≤ 30% 217 126.9 ± 9.1 118.3 ± 11.5 5.3 ± 8.3 0 ~ 20.0 8.0 ± 2.8
\